D

Dragonfly Therapeutics, Inc.

109 employees

Dragonfly Therapeutics is a clinical-stage biotech developing novel immunotherapies that harness the innate immune system to treat disease.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
immuno-oncology

Date founded

2016

Funding rounds raised

D

Dragonfly Therapeutics, Inc. raised undisclosed on May 15, 2017

Investors: Celgene and Agent Capital

FAQ